贝瑞基因
(000710)
| 流通市值：46.83亿 | | | 总市值：50.24亿 |
| 流通股本：3.30亿 | | | 总股本：3.54亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 447,434,341.07 | 217,759,068.08 | 1,078,165,273.94 | 822,664,528.62 |
| 营业收入 | 447,434,341.07 | 217,759,068.08 | 1,078,165,273.94 | 822,664,528.62 |
| 二、营业总成本 | 456,188,384.03 | 214,518,555.65 | 1,072,541,450.25 | 765,979,082.06 |
| 营业成本 | 225,830,709.82 | 110,008,040.12 | 572,909,344.39 | 406,324,355.34 |
| 税金及附加 | 2,366,866.24 | 414,696.25 | 11,236,018.57 | 6,391,977.92 |
| 销售费用 | 100,519,226.84 | 47,819,719.97 | 236,830,171.84 | 171,214,504.94 |
| 管理费用 | 71,666,893.4 | 33,141,322.58 | 148,723,794.38 | 119,317,330.32 |
| 研发费用 | 52,519,317.48 | 21,653,803.47 | 95,419,662.22 | 58,453,739.7 |
| 财务费用 | 3,285,370.25 | 1,480,973.26 | 7,422,458.85 | 4,277,173.84 |
| 其中:利息费用 | 5,513,610 | 2,209,183.91 | 9,831,402.96 | - |
| 其中:利息收入 | 2,557,480.82 | -900,869.89 | 3,522,477.58 | - |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,203,689.24 | -2,276,101.9 | -132,165.22 | -2,230,529.83 |
| 加:投资收益 | 3,257,567.49 | 954,578.63 | -14,553,527.69 | -6,798,926.38 |
| 资产处置收益 | -11,541.91 | -14,866.73 | 1,739,687.32 | 4,598,331.96 |
| 资产减值损失(新) | - | - | -28,078,288.63 | - |
| 信用减值损失(新) | -15,756,033.26 | -5,459,820.52 | -132,930,004.56 | -26,450,355.96 |
| 其他收益 | 578,844.32 | 425,716.91 | 1,717,510.77 | 1,542,459.11 |
| 四、营业利润 | -18,481,517.08 | -3,129,981.18 | -166,612,964.32 | 27,346,425.46 |
| 加:营业外收入 | 6,439.78 | 2,922.26 | 258,807.15 | 234,871.58 |
| 减:营业外支出 | 1,200,420.21 | 618,144.78 | 4,403,254.13 | 1,284,017.73 |
| 五、利润总额 | -19,675,497.51 | -3,745,203.7 | -170,757,411.3 | 26,297,279.31 |
| 减:所得税费用 | 5,734,665.27 | 1,894,516.73 | 17,417,622.98 | 12,352,762.31 |
| 六、净利润 | -25,410,162.78 | -5,639,720.43 | -188,175,034.28 | 13,944,517 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -25,410,162.78 | -5,639,720.43 | -188,175,034.28 | 13,944,517 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -27,242,543.15 | -6,462,206.12 | -192,428,499.73 | 10,385,508.92 |
| 少数股东损益 | 1,832,380.37 | 822,485.69 | 4,253,465.45 | 3,559,008.08 |
| 扣除非经常损益后的净利润 | -28,589,541.41 | -3,682,733.93 | -192,191,901.79 | 12,812,154.91 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.08 | -0.02 | -0.54 | 0.03 |
| (二)稀释每股收益 | -0.08 | -0.02 | -0.54 | 0.03 |
| 八、其他综合收益 | -3,950,510.27 | -814,304.19 | 5,461,696.08 | -480,248.25 |
| 归属于母公司股东的其他综合收益 | -3,294,200.76 | -669,245.91 | 4,595,883.99 | -332,858.02 |
| 九、综合收益总额 | -29,360,673.05 | -6,454,024.62 | -182,713,338.2 | 13,464,268.75 |
| 归属于母公司股东的综合收益总额 | -30,536,743.91 | -7,131,452.03 | -187,832,615.74 | 10,052,650.9 |
| 归属于少数股东的综合收益总额 | 1,176,070.86 | 677,427.41 | 5,119,277.54 | 3,411,617.85 |
| 公告日期 | 2025-08-30 | 2025-04-28 | 2025-04-25 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |